CCDC18 and breast carcinoma: As shown in Figure 7, only high expression of LINC01128, CCDC18-AS1, SH3BP5-AS1, HOTAIRM1, LINC01140, SGMS1-AS1, LINC01578 or LINC00667 had favorable prognosis in breast cancer.